Resona Asset Management Co. Ltd. Sells 37,536 Shares of Revvity Inc. $RVTY

Resona Asset Management Co. Ltd. decreased its holdings in shares of Revvity Inc. (NYSE:RVTY) by 96.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,425 shares of the company’s stock after selling 37,536 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Revvity were worth $138,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Byrne Asset Management LLC raised its position in shares of Revvity by 0.9% during the 4th quarter. Byrne Asset Management LLC now owns 11,138 shares of the company’s stock valued at $1,078,000 after acquiring an additional 100 shares during the last quarter. Allworth Financial LP grew its holdings in shares of Revvity by 8.9% in the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after buying an additional 104 shares during the period. Trust Point Inc. raised its stake in Revvity by 3.8% during the 4th quarter. Trust Point Inc. now owns 3,215 shares of the company’s stock worth $311,000 after buying an additional 117 shares during the period. HighTower Advisors LLC raised its stake in Revvity by 2.6% during the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock worth $497,000 after buying an additional 129 shares during the period. Finally, Farther Finance Advisors LLC lifted its holdings in Revvity by 26.2% during the fourth quarter. Farther Finance Advisors LLC now owns 698 shares of the company’s stock worth $68,000 after acquiring an additional 145 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Trading Down 0.0%

Revvity stock opened at $96.93 on Monday. The firm has a 50-day moving average of $90.69 and a 200-day moving average of $96.99. Revvity Inc. has a one year low of $81.22 and a one year high of $118.30. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The company has a market cap of $10.81 billion, a price-to-earnings ratio of 46.38, a P/E/G ratio of 2.09 and a beta of 1.05.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The company had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. During the same period in the prior year, the business posted $1.01 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, equities analysts expect that Revvity Inc. will post 5.33 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio is currently 13.40%.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Stifel Nicolaus reduced their target price on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a report on Wednesday, May 6th. Jefferies Financial Group lifted their target price on Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. The Goldman Sachs Group reduced their target price on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a report on Tuesday, April 14th. Barclays lifted their target price on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Finally, Robert W. Baird set a $117.00 target price on Revvity in a report on Wednesday, May 6th. Four analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $107.73.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.